Genomic Biomarker Market 2026

January 2026 | 218 pages | ID: GDC542632D9FEN
DataM Intelligence

Abstracts

The Genomic Biomarker Market was valued at in and is anticipated to reach by , at a CAGR of 0.15 from 2026 to 2032.

The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the Genomic Biomarker Market.

This report delivers a comprehensive overview of the Genomic Biomarker Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Genomic Biomarker Market. The Genomic Biomarker Market size, estimates, and forecasts are provided in terms of output/shipments (K MT) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

Genomic Biomarker Market Scope:

By Type

• Predictive Biomarkers
• Prognostic Biomarkers

By Validation

• Analytical Validation
• Clinical Validation
• Clinical Utility
• Others

By Indication

• Oncology
• Cardiovascular Diseases
• Neurological Diseases
• Renal Disorders
• Others

By End-user

• Hospitals
• Diagnostic Centers
• Research Laboratories
• Others

Key Players

• Thermo Fisher Scientific
• Bio-Rad Laboratories, Inc.
• Myriad Genetics, Inc.
• QIAGEN
• Eurofins Scientific
• Exact Sciences
• Sema4
• Creative Diagnostics
• Centogene N.V.
• Quanterix

Major Highlights

This report delivers a comprehensive overview of the Genomic Biomarker Market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Genomic Biomarker Market. The Genomic Biomarker Market size, estimates, and forecasts are provided in terms of output/shipments (K Sqm) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for –.

This report will assist keyword manufacturers, new entrants, and companies across the industry value chain with information on revenues, production, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Regional Analysis:

• North America (U.S., Canada, Mexico)
• Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
• Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
• South America (Colombia, Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Partner Identification

• Increase Your Customer Base by 3X using our Partner Identification tool
• Uncover strategic collaboration opportunities with DataM vetted partners aligned to your ecosystem.
• Identify high potential M&A targets based on synergies, market positioning and growth trajectory.
• Prioritize partners by strategic fit rather than general capability.

Why Choose DataM?

• Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
• Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
• White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
• Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
• Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than offering generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
• Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2026

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Contents

1. METHODOLOGY AND SCOPE

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. MARKET DEFINITION AND OVERVIEW

3. EXECUTIVE SUMMARY

4. MARKET DYNAMICS

4.1. Market Impacting Factors
  4.1.1. Drivers
    4.1.1.1. The growing investment by government authorities in the healthcare industry is expected to drive market growth.
  4.1.2. Restraints:
    4.1.2.1. High costs of genomic biomarkers are expected to hamper market growth.
  4.1.3. Opportunity
  4.1.4. Impact Analysis

5. INDUSTRY ANALYSIS

5.1. Supply Chain Analysis
5.2. Pricing Analysis

6. COVID-19 ANALYSIS

6.1. Analysis of Covid-19 on the Market
  6.1.1. Before COVID-19 Market Scenario
  6.1.2. Present COVID-19 Market Scenario
  6.1.3. After COVID-19 or a Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. BY TYPE

7.1. Introduction
  7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  7.1.2. Market Attractiveness Index, By Type Segment
7.2. Predictive Biomarkers*
  7.2.1. Introduction
  7.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
7.3. Prognostic Biomarkers

8. BY VALIDATION

8.1. Introduction
  8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Validation
  8.1.2. Market Attractiveness Index, By Validation Segment
8.2. Analytical Validation*
  8.2.1. Introduction
  8.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
8.3. Clinical Validation
8.4. Clinical Utility
8.5. Others

9. BY INDICATION

9.1. Introduction
  9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  9.1.2. Market Attractiveness Index, By Indication Segment
9.2. Oncology*
  9.2.1. Introduction
  9.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Cardiovascular Diseases
9.4. Neurological Diseases
9.5. Renal Disorders
9.6. Others

10. BY END-USER

10.1. Introduction
  10.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  10.1.2. Market Attractiveness Index, By End-User Segment
10.2. Hospitals*
  10.2.1. Introduction
  10.2.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
10.3. Diagnostic Centers
10.4. Research Laboratories
10.5. Others

11. BY REGION

11.1. Introduction
  11.1.1. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
  11.1.2. Market Attractiveness Index, By Region
11.2. North America
  11.2.1. Introduction
  11.2.2. Key Region-Specific Dynamics
  11.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  11.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Validation
  11.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  11.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  11.2.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.2.7.1. The U.S.
    11.2.7.2. Canada
    11.2.7.3. Mexico
11.3. Europe
  11.3.1. Introduction
  11.3.2. Key Region-Specific Dynamics
  11.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  11.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Validation
  11.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  11.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  11.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.3.7.1. Germany
    11.3.7.2. The U.K.
    11.3.7.3. France
    11.3.7.4. Italy
    11.3.7.5. Spain
    11.3.7.6. Rest of Europe
11.4. South America
  11.4.1. Introduction
  11.4.2. Key Region-Specific Dynamics
  11.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  11.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Validation
  11.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  11.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  11.4.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.4.7.1. Brazil
    11.4.7.2. Argentina
    11.4.7.3. Rest of South America
11.5. Asia Pacific
  11.5.1. Introduction
  11.5.2. Key Region-Specific Dynamics
  11.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  11.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Validation
  11.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  11.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
  11.5.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
    11.5.7.1. China
    11.5.7.2. India
    11.5.7.3. Japan
    11.5.7.4. Australia
    11.5.7.5. Rest of Asia Pacific
11.6. Middle East and Africa
  11.6.1. Introduction
  11.6.2. Key Region-Specific Dynamics
  11.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Type
  11.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Validation
  11.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Indication
  11.6.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User

12. COMPETITIVE LANDSCAPE

12.1. Key Developments and Strategies
12.2. Company Share Analysis
12.3. Product Benchmarking
12.4. List of Key Companies to Watch

13. COMPANY PROFILES

13.1. Thermo Fisher Scientific*
  13.1.1. Company Overview
  13.1.2. Product Portfolio and Description
  13.1.3. Key Highlights
  13.1.4. Financial Overview
13.2. Bio-Rad Laboratories, Inc.
13.3. Myriad Genetics, Inc.
13.4. QIAGEN
13.5. Eurofins Scientific
13.6. Exact Sciences
13.7. Sema4
13.8. Creative Diagnostics
13.9. Centogene N.V.
13.10. Quanterix (*LIST NOT EXHAUSTIVE)

14. DATAM INTELLIGENCE

14.1. Appendix
14.2. About Us and Applications
14.3. Contact Us